1. Home
  2. GKOS vs HWC Comparison

GKOS vs HWC Comparison

Compare GKOS & HWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$141.22

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Hancock Whitney Corporation

HWC

Hancock Whitney Corporation

HOLD

Current Price

$67.16

Market Cap

5.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
HWC
Founded
1998
1883
Country
United States
United States
Employees
N/A
3627
Industry
Medical/Dental Instruments
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.2B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
HWC
Price
$141.22
$67.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
6
Target Price
$126.92
$77.67
AVG Volume (30 Days)
642.1K
715.1K
Earning Date
04-29-2026
04-21-2026
Dividend Yield
N/A
3.00%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$507,442,000.00
N/A
Revenue This Year
$23.32
$11.59
Revenue Next Year
$27.43
$4.42
P/E Ratio
N/A
$12.48
Revenue Growth
32.33
N/A
52 Week Low
$73.16
$52.89
52 Week High
$145.50
$75.43

Technical Indicators

Market Signals
Indicator
GKOS
HWC
Relative Strength Index (RSI) 73.45 52.99
Support Level $80.14 $66.40
Resistance Level N/A $68.09
Average True Range (ATR) 4.95 1.62
MACD 1.69 -0.11
Stochastic Oscillator 86.28 32.67

Price Performance

Historical Comparison
GKOS
HWC

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About HWC Hancock Whitney Corporation

Hancock Whitney Corp operates bank offices and financial centers. The company offers a range of traditional and online banking services to commercial, small business, and retail customers, providing a variety of transaction and savings deposit products, treasury management services, secured and unsecured loan products (including revolving credit facilities), letters of credit, and similar financial guarantees. The Bank provides trust and investment management services to retirement plans, corporations, and individuals and provides its customers access to investment advisory and brokerage products.

Share on Social Networks: